Skip to main content

M&T Bank Corp

Bank

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 36270 BUFFALO, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$2,853,313
-$2,073,036 QoQ
Shares Held
4,576
-28.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#462
of 1,297 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 93% Shared 0% None 7%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Derivatives in REGN

reported options exposure · as of Jun 30, 2020
CallValue
$1,870
CallShares
3
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

M&T Bank Corp holds $45,025,387 across 46 Biotechnology names. REGN ranks #4 (6.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 REGN
Regeneron Pharmaceuticals, Inc.
This page
4,576 $2,853,313

All Filings in REGN

Export CSV
27 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,853,313 4,576
2026-03-31 $4,926,349 6,376
2025-12-31 $4,966,980 6,435
2025-09-30 $3,001,956 5,339
2025-06-30 $3,112,725 5,929
2025-03-31 $3,225,689 5,086
2024-12-31 $3,823,783 5,368
2024-09-30 $5,760,791 5,480
2024-06-30 $5,524,209 5,256
2024-03-31 $5,361,063 5,570
2023-12-31 $4,680,401 5,329
2023-09-30 $4,462,907 5,423
2023-06-30 $3,878,674 5,398
2023-03-31 $4,433,726 5,396
2022-12-31 $3,244,538 4,497
2022-09-30 $3,576,607 5,192
2022-06-30 $2,865,022 5,920
2022-03-31 $2,973,871 4,258
2021-12-31 $2,673,221 4,233
2021-09-30 $2,550,224 4,214
2021-06-30 $2,268,786 4,062
2021-03-31 $1,937,979 4,096
2020-12-31 $2,698,167 5,585
2020-09-30 $3,479,589 6,216
2020-06-30 $1,870 3
2020-06-30 $4,522,707 7,252
2020-03-31 $3,955,145 8,100